Author:
George Melvin,Selvarajan Sandhiya
Reference42 articles.
1. Wu W, Sargent D. Choice of end points in clinical trials. In: Hallibi S, Kelly K, editors. Oncology clinical trials. New York: Demos Medical Publishing; 2013. p. 35–42.
2. Nottage M, Siu LL. Principles of clinical trial design. J Clin Oncol. 2002;20:42S–6.
3. Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H. The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics. 2000;1:49–67.
4. Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A. Statistical challenges in the evaluation of surrogate endpoints in randomized trials. Control Clin Trials. 2002;23:607–25.
5. Tassinari D. Surrogate end points of quality of life assessment: have we really found what we are looking for? Health Qual Life Outcomes. 2003;1:71.